Raffit Hassan

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains

Carmine Carpenito, Michael C. Milone, Raffit Hassan et al. · Proceedings of the National Academy of Sciences · 2009 · 889 citations · Full text

Life Sciences, Immunology, Oncology +17

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

Hedy L. Kindler, Nofisat Ismaila, Samuel G. Armato et al. · Journal of Clinical Oncology · 2018 · 421 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers

Raffit Hassan, Susie Bullock, Ahalya Premkumar et al. · Clinical Cancer Research · 2007 · 381 citations · Full text

Pharmacy, Oncology, Pharmacology +16

A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction

Dung T. Le, Dirk G. Brockstedt, Ran Nir‐Paz et al. · Clinical Cancer Research · 2011 · 368 citations · Full text

Life Sciences, Immunology, Oncology +17

Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer

Raffit Hassan, Alan T. Remaley, Maureen Sampson et al. · Clinical Cancer Research · 2006 · 289 citations

Medicine, Oncology, Pathology +17